phase 2_completion
saveSoochow University Hospital 1 — blinatumomab (Phase II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Data sources
globaldata
Found something off?
drug timeline · 8
- phase 1 2 completionAbbVie Inc — blinatumomab (Phase I/II Trial Completion)Apr 30, 2026 · 160d ago
- approvalBLINCYTO (BLINATUMOMAB) — FDA approvalOct 21, 2025 · 351d ago
- approvalBLINCYTO (BLINATUMOMAB) — FDA approvalApr 29, 2025 · 526d ago
- approvalBLINCYTO (BLINATUMOMAB) — FDA approvalDec 17, 2024 · 659d ago
- approvalBLINCYTO (BLINATUMOMAB) — FDA approvalJun 14, 2024 · 845d ago
- approvalBLINCYTO (BLINATUMOMAB) — FDA approvalFeb 8, 2024 · 972d ago
- approvalBLINCYTO (BLINATUMOMAB) — FDA approvalJun 20, 2023 · 1205d ago
- approvalBLINCYTO (BLINATUMOMAB) — FDA approvalJun 20, 2023 · 1205d ago
comments(0)
5-min edit window · permanent after that